Bioethics News

Vaccine Tested to Protect Against Mosquito-Borne Diseases

February 21, 2017

(UPI) – Researchers from the National Institutes of Health, or NIH, are testing a new vaccine designed to target mosquito saliva to protect against mosquito-borne diseases. The National Institute of Allergy and Infectious Diseases, or NIAID, part of the NIH, has launched a Phase 1 clinical trial of a new vaccine that could provide widespread protection against a variety of mosquito-borne diseases like Zika, malaria, West Nile virus and dengue fever.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.